Plasma Concentrations, Efficacy and Safety of Efavirenz in HIV-Infected Adults Treated for Tuberculosis in Cambodia (ANRS 1295-CIPRA KH001 CAMELIA Trial).
Authors
Borand, LaurenceMadec, Yoann
Laureillard, Didier
Chou, Monidarin
Marcy, Olivier
Pheng, Phearavin
Prak, Narom
Kim, Chindamony
Lak, Khemarin Kim
Hak, Chanroeun
Dim, Bunnet
Nerrienet, Eric
Fontanet, Arnaud
Sok, Thim
Goldfeld, Anne E
Blanc, François-Xavier
Taburet, Anne-Marie
Issue Date
2014
Metadata
Show full item recordJournal
PloS ONEAbstract
To assess efavirenz plasma concentrations and their association with treatment efficacy and tolerance of efavirenz 600 mg daily in HIV-tuberculosis co-infected patients.Publisher
Public Library of SciencePubMed ID
24608960Language
enISSN
1932-6203ae974a485f413a2113503eed53cd6c53
10.1371/journal.pone.0090350
Scopus Count
Collections
Related articles
- Plasma concentrations of efavirenz with a 600 mg standard dose in Cambodian HIV-infected adults treated for tuberculosis with a body weight above 50 kg.
- Authors: Borand L, Laureillard D, Madec Y, Chou M, Pheng P, Marcy O, Sok T, Goldfeld AE, Taburet AM, Blanc FX, CAMELIA ANRS 1295-CIPRA KH001 Study Team.
- Issue date: 2013
- CYP2B6 18492T->C polymorphism compromises efavirenz concentration in coinfected HIV and tuberculosis patients carrying CYP2B6 haplotype *1/*1.
- Authors: Manosuthi W, Sukasem C, Thongyen S, Nilkamhang S, Manosuthi S, Sungkanuparph S
- Issue date: 2014
- Nevirapine or efavirenz for tuberculosis and HIV coinfected patients: exposure and virological failure relationship.
- Authors: Bhatt NB, Baudin E, Meggi B, da Silva C, Barrail-Tran A, Furlan V, Grinsztejn B, Bonnet M, Taburet AM, ANRS 12146/12214-CARINEMO Study Group.
- Issue date: 2015 Jan
- Effect of Rifampin-Isoniazid-Containing Antituberculosis Therapy on Efavirenz Pharmacokinetics in HIV-Infected Children 3 to 14 Years Old.
- Authors: Kwara A, Yang H, Antwi S, Enimil A, Gillani FS, Dompreh A, Ortsin A, Opoku T, Bosomtwe D, Sarfo A, Wiesner L, Norman J, Alghamdi WA, Langaee T, Peloquin CA, Court MH, Greenblatt DJ
- Issue date: 2019 Jan
- A randomized trial comparing plasma drug concentrations and efficacies between 2 nonnucleoside reverse-transcriptase inhibitor-based regimens in HIV-infected patients receiving rifampicin: the N2R Study.
- Authors: Manosuthi W, Sungkanuparph S, Tantanathip P, Lueangniyomkul A, Mankatitham W, Prasithsirskul W, Burapatarawong S, Thongyen S, Likanonsakul S, Thawornwa U, Prommool V, Ruxrungtham K, N2R Study Team.
- Issue date: 2009 Jun 15